Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Warfarin withdrawal in atrial fibrillation patients awaiting surgery dramatically ups stroke risk

Written by: | editors@medicalnewstoday.com | Dated: Tuesday, April 21st, 2015

Researchers have quantified the risk of ischemic stroke in patients with atrial fibrillation when warfarin is discontinued for surgical procedures.
CT scan of ischemic stroke
Before the present study, the risk of ischemic stroke during periods of warfarin discontinuation for surgical procedures had long been acknowledged but not well characterized.

Dr. Adnan I. Qureshi, with Zeenat Qureshi Stroke Institute in St. Cloud, Minnesota, and colleagues evaluated the association of warfarin discontinuation for surgical procedures with the incidence of ischemic stroke in a cohort of patients with nonvalvular atrial fibrillation.

All subjects had been randomized into the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study.

After controlling for potential confounders including age, gender, obesity, diabetes mellitus, hypercholesterolemia and cigarette smoking, warfarin cessation was associated with an increased risk for ischemic stroke (relative risk: 5.6, 95% CI, 1.8 to 17.8 p=0.003) in 4,060 patients who were followed for a mean of 3.5 years.

Dr. Qureshi reported the findings at the 67th Annual Meeting of the American Academy of Neurology.

Subjects included in the analysis had atrial fibrillation plus at least one additional risk factor for stroke or death: age >65 years, systemic hypertension, diabetes, congestive heart failure, transient ischemic attack, prior stroke, left atrium diameter 50+ mm, left ventricular fractional shortening <25%, or left ventricular ejection fraction <40%.

Before the present study, the risk of ischemic stroke during periods of warfarin discontinuation for surgical procedures had long been acknowledged but not well characterized, Dr. Qureshi said. 
 The analysis demonstrated that the ischemic stroke rate was 1.1% and 0.2% for individuals with and without warfarin discontinuation, respectively, P=0.001.

Stroke risk with warfarin discontinuation was similar in men and women.

Dr. Qureshi emphasized that the risk associated with discontinuation of warfarin for procedures must be recognized and considered in the risk-benefit analysis of any surgical procedure. 

Written by Jill Stein

Source: Medical News Today

Leave a Reply

Be the First to Comment!


 

Ad Right Top

MedAdNews

Extensive pharmaceutical business MAN 1504 Cover 300pixand marketing intelligence. If you would like to purchase a back issue, please contact our customer service department at MDAD@kmpsgroup.com, or call 800-869-6882.

April 2015 Focus: Healthcare Communications Agencies

Subscribe

Ad Right Bottom

Marketing Communications Directory

Marketing Communications Directory

Healthcare Communications Agencies & Marketing Services Directory

Contract Research Directory

Contract Research Directory

Qualified Clinical Research Organizations Directory

Main Navigation
Password Reset
Please enter your e-mail address. You will receive a new password via e-mail.